Thrombosis of vein grafts: Wall tension restrains thrombomodulin expression

Circulation Research

Volumn 92, Issue 1, 2003, Pages 12-13

  Lentz, Steven R ^a  

^a NONE

Author keywords

Endothelium; Strain; Thrombin; Thrombomodulin; Vein graft

Indexed keywords

ACTIVATED PROTEIN C; CYTOKINE; INTERLEUKIN 1BETA; THROMBOMODULIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTERIAL CIRCULATION; BLOOD VESSEL WALL; CAROTID ARTERY; CYTOKINE PRODUCTION; DISEASE MODEL; DISSEMINATED INTRAVASCULAR CLOTTING; EDITORIAL; EPCR GENE; GENE ISOLATION; HUMAN; HUMAN CELL; INFLAMMATION; JUGULAR VEIN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; REGULATORY MECHANISM; SEPSIS; SHEAR STRESS; STENT; THROMBOSIS PREVENTION; VEIN GRAFT; VEIN THROMBOSIS;

ANIMALS; BLOOD COAGULATION FACTORS; BLOOD PRESSURE; ENDOTHELIUM, VASCULAR; HUMANS; RABBITS; RECEPTORS, CELL SURFACE; STRESS, MECHANICAL; THROMBIN; THROMBOMODULIN; TRANSPLANTATION; VASOMOTOR SYSTEM; VEINS; VENOUS THROMBOSIS;

EID: 0037428175     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000052828.62011.3C     Document Type: Editorial

References (20)

1. Motwani JG, Topol EJ. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation. 1998;97:916-931.
2. Edelberg JM, Christie PD, Rosenberg RD. Regulation of vascular bedspecific prothrombotic potential. Circ Res. 2001;89:117-124.
3. Esmon CT, Gu JM, Xu J, Qu DF, Steams-Kurosawa DJ, Kurosawa S. Regulation and functions of the protein C anticoagulant pathway. Haematologica. 1999;84:363-368.
4. Esmon CT. Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function at the vessel surface. FASEB J. 1995;9:946-955.
5. Taylor FB, Peer GT. Lockhart MS, Ferrell G, Esmon CT. Endothelial cell protein C receptor plays an important role in protein C activation in vivo. Blood. 2001;97:1685-1688.
6. Kearon C, Crowther M, Hirsh J. Management of patients with hereditary hypercoagulable disorders. Annu Rev Med. 2000;51:169-185.
7. Kim AY, Walinsky PL, Kolodgie FD, Bian C, Sperry JL, Deming CB, Peck EA, Shake JG, Ang GB, Sohn RH, Esmon CT, Virmani R, Stuart RS, Rade JJ. Early loss of thrombomodulin expression impairs vein graft thromboresistance: implications for vein graft failure. Circ Res. 2002;90:205-212.
8. Gosling M, Golledge J, Turner RJ, Powell JT. Arterial flow conditions downregulate thrombomodulin on saphenous vein endothelium. Circulation. 1999;99:1047-1053.
9. Cook JM, Cook CD, Marlar R, Solis MM, Fink L, Eidt JF. Thrombomodulin activity on human saphenous vein grafts prepared for coronary artery bypass. J Vasc Surg. 1991;14:147-151.
10. Esmon CT. New mechanisms for vascular control of inflammation mediated by natural anticoagulant proteins. J Exp Med. 2002;196:561-564.
11. Boehme MW, Deng Y, Raeth U. Bierhaus A, Ziegler R, Stremmel W, Nawroth PP. Release of thrombomodulin from endothelial cells by concerted action of TNT-α and neutrophils: in vivo and in vitro studies. Immunology. 1996;87:134-140.
12. Maiek AM, Jackman R, Rosenberg RD, Izumo S. Endothelial expression of thrombomodulin is reversibly regulated by fluid shear stress. Circ Res. 1994;74:852-860.
13. Takada Y, Shinkai F, Kondo S, Yamamoto S, Tsuboi H, Korenaga R, Ando J. Fluid shear stress increases the expression of thrombomodulin by cultured human endothelial cells. Biochem Biophys Res Comm. 1994;205:1345-1352.
14. Sperry JL, Deming CB, Bian C, Walinsky PL, Kass DA, Kolodgie FD, Virmani R, Kim AY, Rade JJ. Wall tension is a potent negative regulator of in vivo thrombomodulin expression. Circ Res. 2003;92:41-47.
15. Laszik ZG, Zhou XJ, Ferrell GL, Silva FG, Esmon CT. Down-regulation of endothelial expression of endothelial cell protein C receptor and thrombomodulin in coronary atherosclerosis. Am J Pathol. 2001;159:797-802.
16. Lentz SR, Fernandez JA, Griffin JH, Piegors DJ, Erger RA. Malinow MR, Heistad DD. Impaired anticoagulant response to infusion of thrombin in atherosclerotic monkeys associated with acquired defects in the protein C system. Anerioscl Thromb Vasc Biol. 1999;19:1744-1750.
17. Lentz SR, Miller FJ, Jr., Piegors DJ, Erger RA, Fernandez JA, Griffin JH, Heistad DD. Anticoagulant responses to thrombin are enhanced during recession of atherosclerosis in monkeys. Circulation. 2002;106:842-846.
18. Waugh JM, Yuksel E, Li J, Kuo MD, Kattash M, Saxena R, Geske R, Thung SN, Shenaq SM, Woo SLC. Local overexpression of thrombomodulin for in vivo prevention of arterial thrombosis in a rabbit model. Circ Res. 1999;84:84-92.
19. Izzat MB. Mehta D, Bryan AJ, Reeves B, Newby AC, Angelini GD. Influence of external stent size on early medial and neointimal thickening in a pig model of saphenous vein bypass grafting. Circulation. 1996;94:1741-1745.
20. Weitz JI, Buller HR. Direct thrombin inhibitors in acute coronary syndromes: present and future. Circulation. 2002;105:1004-1011.